CIPO Patents = 3

EPO Patents = 1

Forward Citations = 18

Loading Chart...

7 inventors (with patents filed for the assignee):

John Edward Davies (6 out of 15 patents)

Dolores Baksh (4 out of 7 patents)

Rahul Sarugaser (4 out of 6 patents)

4. Morris Hosseini (4 out of 4 patents)

5. Antony D S Lickorish (4 out of 4 patents)

6. Jane Elizabeth Ennis (2 out of 2 patents)

7. Jeffrey Donald Turner (2 out of 2 patents)

6 patents: Sort by Forward Citations

1. 9611456 - Progenitor cells from wharton'S jelly of human umbilical cord (2017-04-04),

2. 9567564 - Progenitor cells from Wharton's jelly of human umbilical cord (2017-02-14),

3. 9498544 - Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents (2016-11-22),

4. 9005599 - Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents (2015-04-14),

5. 8481311 - Progenitor cells from wharton's jelly of human umbilical cord (2013-07-09),

6. 7547546 - Progenitor cells from wharton's jelly of human umbilical cord (2009-06-16),

Tissue Regeneration Therapeutics Inc. is a leading biotechnology company specializing in the development of advanced regenerative therapies for tissue repair and regeneration. With a focus on cutting-edge research and innovative technology, TRT is dedicated to improving patient outcomes and revolutionizing the field of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#216 in Toronto

#2,331 in Canada

Toronto, Canada

Tissue Regeneration Therapeutics Inc.

Forward Citations = 18

7 inventors:

John Edward Davies (6 out of 15 patents)

Dolores Baksh (4 out of 7 patents)

Rahul Sarugaser (4 out of 6 patents)

4. Morris Hosseini (4 out of 4 patents)

5. Antony D S Lickorish (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

3 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com